Coherus Oncology Inc
(CHRS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -171,358 | -99,873 | -40,839 | -87,177 | -58,154 |
| Depreciation Amortization | 1,268 | 632 | 232 | 674 | 439 |
| Accounts receivable | 3,730 | 2,816 | 402 | -3,954 | 278 |
| Accounts payable and accrued liabilities | 20,172 | 10,568 | 4,730 | 5,266 | 5,132 |
| Other Working Capital | 40,482 | 34,296 | 1,171 | 28,434 | 39,728 |
| Other Operating Activity | -7,851 | -2,341 | 1,242 | 32,830 | 21,935 |
| Operating Cash Flow | $-113,557 | $-53,902 | $-33,062 | $-23,927 | $9,358 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,720 | -2,321 | -1,313 | -2,849 | -2,360 |
| Net Acquisitions | N/A | N/A | N/A | 2,334 | 2,334 |
| Other Investing Activity | -785 | 0 | 0 | -10 | 0 |
| Investing Cash Flow | $-5,505 | $-2,321 | $-1,313 | $-525 | $-26 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 113,815 | 547 | 168 | 85,474 | 19 |
| Common Stock Repurchased | N/A | N/A | N/A | -2 | -2 |
| Other Financing Activity | 8,544 | 111,349 | -897 | 50,484 | 52,173 |
| Financing Cash Flow | $122,359 | $111,896 | $-729 | $135,956 | $52,190 |
| Exchange Rate Effect | 2 | 23 | -152 | -666 | -201 |
| Beginning Cash Position | 150,392 | 150,392 | 150,392 | 39,554 | 39,554 |
| End Cash Position | 153,691 | 206,088 | 115,136 | 150,392 | 100,875 |
| Net Cash Flow | $3,299 | $55,696 | $-35,256 | $110,838 | $61,321 |
| Free Cash Flow | |||||
| Operating Cash Flow | -113,557 | -53,902 | -33,062 | -23,927 | 9,358 |
| Capital Expenditure | -4,720 | -2,321 | -1,313 | -2,849 | -2,360 |
| Free Cash Flow | -118,277 | -56,223 | -34,375 | -26,776 | 6,998 |